Is aripiprazole the only choice of treatment of the patients who developed anti-psychotic agents-induced leucopenia and neutropenia? A case report

Leucopenia and neutropenia could be side effects of anti-psychotic drugs, especially clozapine. However, there is evidence that other anti-psychotics can cause leucopenia and neutropenia. We present the clinical follow-up and treatment process of a patient, who had initially developed quetiapine and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of psychopharmacology (Oxford) 2008-05, Vol.22 (3), p.333-335
Hauptverfasser:	Yalcin, Demet Ozen, Goka, Erol, Aydemir, M Cigdem, Kisa, Cebrail
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antipsychotic Agents - adverse effects Antipsychotic Agents - therapeutic use Aripiprazole Biological and medical sciences Blood Cell Count Case studies Diagnosis Dibenzothiazepines - adverse effects Dibenzothiazepines - therapeutic use Dosage and administration Drug toxicity and drugs side effects treatment Female Hematologic and hematopoietic diseases Humans Leucopenia Leukopenia - blood Leukopenia - chemically induced Medical sciences Neuropharmacology Neutropenia Neutropenia - blood Neutropenia - chemically induced Other diseases. Hematologic involvement in other diseases Pharmacology. Drug treatments Piperazines - therapeutic use Psycholeptics: tranquillizer, neuroleptic Psychology. Psychoanalysis. Psychiatry Psychopharmacology Psychotic Disorders - complications Psychotic Disorders - drug therapy Psychotic Disorders - psychology Quetiapine Fumarate Quinolones - therapeutic use Risk factors Sulpiride - adverse effects Sulpiride - analogs & derivatives Toxicity: blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Leucopenia and neutropenia could be side effects of anti-psychotic drugs, especially clozapine. However, there is evidence that other anti-psychotics can cause leucopenia and neutropenia. We present the clinical follow-up and treatment process of a patient, who had initially developed quetiapine and amisulpride related neutropenia, but not with aripiprazole.
ISSN:	0269-8811 1461-7285
DOI:	10.1177/0269881107081559